ArticleTranslational cancer research2022

Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinoma.

Qingsheng You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.